申请人:AJINOMOTO CO., INC.
公开号:EP3438091A1
公开(公告)日:2019-02-06
The present invention aims to provide a compound useful for the prophylaxis or treatment of diabetes and obesity, and diseases related thereto. The present invention relates to a glucagon-like peptide-1 receptor action enhancer containing a compound represented by the formula (I):
wherein each symbol is as defined in the present specification, or a salt thereof.
本发明旨在提供一种用于预防或治疗糖尿病和肥胖症及其相关疾病的化合物。本发明涉及一种胰高血糖素样肽-1 受体作用增强剂,其中含有由式(I)代表的化合物:
其中各符号如本说明书所定义,或其盐。